Skip to main content
. 2017 Oct 16;14(6):8213–8219. doi: 10.3892/ol.2017.7196

Figure 2.

Figure 2.

Prognostic impact of TERT promoter mutation and telomere length in GBMs. OS of patients with GBM, depending on (A) TERT promoter mutation status and (B) TL. PFS of patients with GBM, depending on (C) TERT promoter mutation status and (D) TL. TERT, telomerase reverse transcriptase gene; GBM, glioblastoma multiforme; TL, telomere length; PFS, progression-free survival; Wk, week.